BGB-A317-205

Completed

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Beigene Study ID info

BGB-A317-205

ClinicalTrials.gov ID info

China Drug Trials ID info

CTR20170515

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents